• registry

    COVID-19 Registry Launched to Track Pregnant Women and Newborns

    According to the American College of Obstetricians and Gynecologists, we have limited information regarding COVID-19 during pregnancy; however, in the absence of adequate information, we consider pregnant women to be an at-risk population for [...]

    New Research from the CWMH: Quetiapine (Seroquel) and Pregnancy Data from the National Registry

    The newer “atypical” or second-generation antipsychotic agents are now used  to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders.  The National Pregnancy Registry for Atypical Antipsychotics [...]

    New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

    Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

    New Research from the CWMH: Reassuring Data from the National Pregnancy Registry of Atypical Antipsychotics

    Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

    Use of Antipsychotic Medications in Pregnancy Increases Risk of Gestational Diabetes

    Atypical antipsychotic medications are commonly used for the treatment of schizophrenia and bipolar disorder.  Despite the increasing use of these medications in women of child-bearing age, there is still relatively little data regarding the reproductive safety of these medications. 

    Go to Top